BARCELONA, SPAIN — In the Post-Operative Pericardial Effusion-2 (POPE-2) trial, once again, the anti-inflammatory drug colchicine was not effective for warding off complications following cardiac ...

Please provide your email address to receive an email when new articles are posted on . BARCELONA, Spain — Colchicine is not an effective treatment for patients who develop postoperative pericardial ...

BARCELONA, Spain – Saturday 30 August: The anti-inflammatory drug colchicine is not an effective treatment for cardiac patients who develop a condition called post-operative pericardial effusion (POPE ...

August 30, 2010 (Stockholm, Sweden) — The first large-scale double-blind, placebo-controlled trial to test the efficacy of colchicine to prevent the development of postpericardiotomy syndrome (PPS) ...

Colchicine does not significantly reduce perioperative atrial fibrillation (AF) or myocardial injury after non-cardiac surgery (MINS) in patients undergoing major non-cardiac thoracic surgery, ...

Overview: Colchicine tablets, capsules, and liquid are used to reduce complications from coronary artery disease, treat Familial Mediterranean Fever, and treat or prevent gout attacks. The most common ...

The findings of the COPPS trial, which have been published in the European Heart Journal by Massimo Imazio and colleagues, indicate that colchicine safely prevents the postpericardiotomy syndrome (PPS ...

Cardiac tamponade is a serious medical condition in which your heart can’t pump enough blood to your body due to fluid buildup around your heart. Seek medical help immediately if you or someone you ...

PERICARDIAL inflammation is a relatively common complication of uremia. Although its occurrence seems superficially related to the degree of renal failure the pathogenesis is still obscure. The ...